Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

UNICHEM

  • FDA Approval
  • Sept. 06, 2024, 04:15 UTC
  • 54
  • 0 comments

FDA approve LACOSAMIDE

Comment Full text

NOVARTIS

  • FDA Approval
  • Sept. 05, 2024, 08:43 UTC
  • 46
  • 0 comments

FDA approve OXCARBAZEPINE

Comment Full text

HENGRUI PHARMA

  • FDA Approval
  • Sept. 05, 2024, 08:43 UTC
  • 48
  • 0 comments

FDA approve CASPOFUNGIN ACETATE

Comment Full text

NOVARTIS

  • FDA Approval
  • Sept. 05, 2024, 08:43 UTC
  • 52
  • 0 comments

FDA approve OXCARBAZEPINE

Comment Full text

INVAGEN PHARMS

  • FDA Approval
  • Sept. 05, 2024, 08:43 UTC
  • 53
  • 0 comments

FDA approve LINAGLIPTIN

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Sept. 05, 2024, 08:43 UTC
  • 50
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

PROVEPHARM SAS

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 40
  • 0 comments

FDA approve DIHYDROERGOTAMINE MESYLATE

Comment Full text

BAXTER HLTHCARE CORP

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 41
  • 0 comments

FDA approve NALOXONE HYDROCHLORIDE

Comment Full text

CHARTWELL RX

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 40
  • 0 comments

FDA approve GLYCOPYRROLATE

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 47
  • 0 comments

FDA approve PREGABALIN

Comment Full text
  • Previous
  • 361
  • 362
  • 363
  • 364
  • 365
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3374)
  • SEC News(216355)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137541)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin